Fig. 1
From: Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
Flowchart of the operational mode for patient inclusion. AD Alzheimer’s disease, CSF cerebrospinal fluid, FTD frontotemporal dementia, MCI mild cognitive impairment